UNSPSC 51111768: Vindesine

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C43H55N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RSA8KO39WH, chemically known as vincaleukoblastine, 3-(aminocarbonyl)-o(sup 4)-deacetyl-3-de(methoxycarbonyl)- but generally known as vindesine, which bears US NIH Compound Identifier 40839. European Medicines Agency schedules Vindesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00061MIG.

UNSPSC 51111768 Vindesine, a Commodity code, does not see active state and local procurement aligned with its nominal scope. The most recent opportunities tagged to this code involve naloxone and drug deactivation systems (Seminole County, Florida) and antibiotic tablets under a pharmaceutical piggyback award (Illinois Department of Public Health), neither of which are vindesine or chemotherapy agents. The code's abstract name—a vinca alkaloid used in cancer treatment—does not match what state and local health and public-safety buyers are actually sourcing under this classification today. State and local governments do acquire pharmaceuticals and medical supplies through cooperative purchasing vehicles and direct procurement, but the recent opportunities in this code's record set signal either misclassification or dormancy in the vindesine category itself.

The Illinois Department of Public Health awarded a $2.999 billion pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for antibiotic tablets under Bid Number 26-482DPH-PREPD-B-53392; this was a completed Invitation for Bid with no open procurement window. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, with a July 26, 2023 response deadline, for 1,900 units of naloxone and 800 drug deactivation systems annually to support community health initiatives. Neither opportunity is aligned with vindesine procurement. Without evidence of active, vindesine-specific state and local solicitations, this code does not present a clear pursuit opportunity at this time.